Clinical trials, real-world data and digital biomarkers are turning artificial intelligence into a practical ally in the fight against depression. The post How AI Is Helping Psychiatrists Make Faster, Smarter Treatment Decisions appeared first on MedCity News.
[Sponsored] Zelis highlights, through a recent survey, how employers, payers, and consumers are integrating digital tools to manage healthcare costs. The findings provide a comprehensive view of the healthcare financial landscape, bringing together stakeholder perspectives, priorities and the opportunities to address them. The post Survey on the Healthcare Financial Landscape Offers a Roadmap for Stakeholders…
As cell-based therapies grow more complex and manufacturing networks expand, resilience can’t be an afterthought, and cryopreservation can no longer just be a step that gets validated during development and left alone. It needs to play an ongoing role in product consistency, potency, and reliability. The post Frozen Does Not Mean Stable: Rethinking Cryopreservation in…
Co-occurring ADHD and eating disorders can intensify the symptoms of each other. Impulsivity can lead to binge eating or purging and emotional dysregulation can make it challenging to cope with life’s difficulties. Addressing both ADHD and an eating disorder at the same time can best forge the path to recovery and healthy coping. The post…
Hospital M&A activity slowed quite a bit in the first half of 2025, with deal volume and transacted revenue falling sharply amid economic uncertainty and sweeping policy changes. While traditional mergers may remain sluggish, analysts expect a rise in outpatient partnerships and rural hospital conversions toward the end of the year. The post Hospital M&A…
A new analysis shows that individuals with employer insurance could save 41% on their out-of-pocket spending for asthma and COPD inhalers through manufacturer savings. In response to a U.S. Senate investigation into inhaler costs, 3 drug makers voluntarily capped out-of-pocket costs on their brand-name asthma and COPD inhalers.
The issue of affordability has reignited a long-simmering battle between California’s medical industry and one of its largest health worker unions. SEIU-United Healthcare Workers West, with approximately 120,000 members, has put forward two ballot initiatives to cap the pay of medical executives and require community clinics to spend the vast bulk of their revenues on…
Cardiovascular disease drugs in development intended to reduce lipoprotein (a) are mostly injectable medications, though Eli Lilly also has both oral and injectable drugs in the clinic. AstraZeneca aims to hit that key protein target with an oral small molecule licensed from CSPC Pharmaceutical Group. The post AstraZeneca Expands Cardiovascular Disease Prospects, Paying $100M for…
In recent years, providers have been increasingly conducting tech pilots to see which solutions can best improve their clinical and operation success. During a panel at MedCity News’ INVEST Digital Health conference in Dallas, healthcare leaders shared their insight on how startups can best serve their provider partners during these pilots. The post 4 Things…
The Department of Justice and the state of Ohio filed an antitrust lawsuit against OhioHealth this week, alleging the health system used “all-or-nothing” contracts that force insurers to include all of its hospitals and physicians. The case highlights federal and state scrutiny of hospital consolidation and restrictive contracting practices — with potential implications for payers,…